The Burden of Diabetes in Missouri

Diabetes is an epidemic in the United States, especially in Missouri. Learn more about the prevalence of diabetes in Missouri, its economic costs, and relevant research projects.

Diabetes is an epidemic in the United States. According to the Centers for DiseaseControl and Prevention (CDC), over 34 million Americans have diabetes and face its devastating consequences.

What’s true nationwide is also true in Missouri. Missouri’s diabetes epidemic:

• Approximately 546,090 people in Missouri, or 11.4% of the adult population, have diagnosed diabetes.
• An additional 139,000 people in Missouri have diabetes but don’t know it, greatly increasing their health risk.
• There are 1,594,000 people in Missouri, 33.6% of the adult population, who have prediabetes with blood glucose levels that are higher than normal but not yet high enough to be diagnosed as diabetes.
• Every year an estimated 42,469 people in Missouri are diagnosed with diabetes.

Diabetes is expensive:

People with diabetes have medical expenses approximately 2.3 times higher than those who do not
have diabetes.
• Total direct medical expenses for diagnosed diabetes in Missouri were estimated at $4.9 billion
in 2017.
• In addition, another $1.8 billion was spent on indirect costs from lost productivity due to diabetes.
Improving lives, preventing diabetes and finding a cure:

In 2021, the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health invested $61,290,467 in diabetes-related research projects in Missouri.

The Division of Diabetes Translation at the CDC provided $1,699,295 in diabetes prevention and educational grants in Missouri in 2018.

Sources include:
• Diabetes Prevalence: 2018 state diagnosed diabetes prevalence,; 2017 state undiagnosed diabetes prevalence, Dall et al., “The Economic Burden of Elevated Blood Glucose Levels in 2017”, Diabetes Care, September 2019, vol. 42.
• Diabetes Incidence: 2018 diabetes incidence rate,
• Cost: American Diabetes Association, “Economic Costs of Diabetes in the U.S. in 2017”, Diabetes Care, May 2018.
• Research expenditures: 2021 NIDDK funding,; 2020 CDC diabetes funding,


On Key

Related Posts